Book Online or Call 1-855-SAUSALITO
Sign In \| Register \| About Sausalito \| Contact Us
Sausalito, CA September 01, 2020 1:41pm 7-Day Forecast \| Traffic

- Apartments

Search Hotels in Sausalito
CHECK-IN:
CHECK-OUT:
ROOMS:

Find A Business
or Browse Listings

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

58.93 +0.39 (+0.67%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

44 45 Next >

SCYNEXIS (NASDAQ: SCYX) Enters Into Exclusive Agreement with GSK (NYSE: GSK) to Continue Commercializing Brexafemme to Treat Fungal Infections

March 30, 2023

SCYNEXIS, Inc. (NASDAQ: SCYX) operates as a biotechnology company, which is focused on the research and development of novel solutions

Via Spotlight Growth

GSK Bets On Scynexis' FDA-Approved Antifungal Drug For Over $500M In Bio Bucks ↗

March 30, 2023

Via Benzinga

Why Is Scynexis (SCYX) Stock Up 69% Today? ↗

March 30, 2023

Scynexis (SCYX) stock is taking off on Tuesday as investors react to news of an exclusive license agreement for Brexafemme.

Via InvestorPlace

Viatris Among Three Companies Licensed To Make GSK/Pfizer-Backed Long Acting HIV Prevention Drug ↗

March 30, 2023

Via Benzinga

Johnson & Johnson Pulls Plug On Large Late-Stage Study Of RSV Vaccine Candidate; GSK, Pfizer Shots Are Under FDA Review ↗

March 29, 2023

Via Benzinga

GSK Stock Skids On Judge's New Ruling As Zantac Trial Looms ↗

March 24, 2023

A trial this summer will examine one Zantac user's cancer.

Via Investor's Business Daily

This Is What Whales Are Betting On GSK ↗

March 23, 2023

Via Benzinga

Daily Stock Analysis: GSK ↗

March 17, 2023

By my dogcatcher ideal, this is a proper time to buy GSK shares, based on their dividends for 2023.

Via Talk Markets

J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out ↗

March 29, 2023

The company says it's refocusing its portfolio to focus on transformational medicines.

Via Investor's Business Daily

GSK Unveils Detailed Phase 3 Data For Jemperli In Frontline Endometrial Cancer Patients ↗

March 28, 2023

Via Benzinga

Sanofi, Regeneron Shares Pop On Big News About COPD Treatment

March 27, 2023

Sanofi and Regeneron bolted higher on news about their jointly developed COPD medication Dupixent. Analysts say sales may hit $20 billion within a decade.

Via MarketBeat

Recent Stock Purchases For March 2023 ↗

March 25, 2023

As readers may know by now, I make stock purchases every single month, no matter what is going on in the world. This month, I went heavier than I normally do, deploying over $3,000. Let's take a look.

Via Talk Markets

Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information ↗

March 21, 2023

Via Benzinga

How Is The Market Feeling About GSK? ↗

March 15, 2023

Via Benzinga

Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories ↗

March 20, 2023

Reuters

Via Benzinga

Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case' ↗

March 20, 2023

Via Benzinga

3 Pharma Stocks That Could Benefit from Global Healthcare Trends ↗

March 17, 2023

The best pharma stocks to buy are those that are poised to be greatly boosted by drugs that are well-positioned to become blockbusters.

Via InvestorPlace

Better RSV Vaccine Stock: Pfizer, GSK, or Moderna? ↗

March 17, 2023

An approved RSV vaccine could be the next big thing for these companies.

Via The Motley Fool

GSK's Chief Scientist Says R&D Focus More On Infectious Disease, HIV Amid Patent Expiration, Dwindling Sales ↗

March 15, 2023

GSK Plc's (NYSE: GSK) top scientist, Tony Wood, who took the helm of R&D last August, says the R&D department is now delivering results. Wood said he is de-emphasizing R&D in oncology and that the R&D...

Via Benzinga

GSK and Earvin “Magic” Johnson Partner to Raise Awareness of Risk of RSV in Older Adults

March 14, 2023

From GSK plc

Via Business Wire

3 High Dividend Stocks With Attractive Total Return Potential ↗

March 10, 2023

In the current economic environment, it is crucial for investors to prioritize quality, reliable dividend stocks and high total returns.

Via InvestorPlace

Sanofi, AstraZeneca Tee Up A Rival To Pfizer In The Multibillion-Dollar RSV Race ↗

March 08, 2023

These companies aren't working on a vaccine, but a monoclonal antibody.

Via Investor's Business Daily

Schrodinger is an AI-Powered Drug Discovery Developer to Watch

March 08, 2023

Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117

Via MarketBeat

Topics Artificial Intelligence

Could This Be the Next Blockbuster Vaccine for This Big Pharma Stock? ↗

March 05, 2023

This vaccine candidate could help tackle the respiratory syncytial virus.

Via The Motley Fool

March 2023 Stock Considerations ↗

March 04, 2023

The calendar has turned, and a new trading month is upon us. 2023 is flying by as two months are already in the books, and that fact simply highlights the importance of staying invested in the stock...

Via Talk Markets

FDA Fuels Respiratory Syncytial Virus Vaccine Race While Backing GSK's Candidate Soon After Pfizer's ↗

March 02, 2023

Via Benzinga

3 Crucial Things to Know About Moderna Right Now ↗

February 27, 2023

This vaccine leader is preparing for a post-pandemic world.

Via The Motley Fool

GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023 ↗

February 24, 2023

The first scheduled trial expected next week, related to GSK Plc's (NYSE: GSK) Zantac associated with cancer, has been postponed, likely by several months.

Via Benzinga

Wall Street's Most Accurate Analysts Say Hold These 3 Healthcare Stocks Delivering High-Dividend Yields ↗

February 23, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With Gilead's: Study Shows ↗

February 23, 2023

Via Benzinga

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

44 45 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Search Hotels in Sausalito

Find A Business

or Browse Listings

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)